Hello, Fool! | Login | Signup | My Fool
Oct 12, 2008 12:48 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
View All Commentary (BPAX)
Recs
pranilbalram (66.87) Submitted: 6/19/08 4:21 PM : Start Price: $5.45 BPAX Score: -8.76
Nice pipeline of products and exhibits the potential for a buyout. Very high debt ratio so the risk is high, however, strong working capital is present.
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK